This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
consumer-staples: Archive
Celsius Holdings Bets on Brand Synergies to Drive Long-Term Scale
by Vrishali Bagree
CELH sees tighter brand integration across Celsius, Alani Nu and Rockstar as a path to greater scale, efficiency and retail execution.
consumer-staples
New Strong Sell Stocks for December 29th
by Zacks Equity Research
ENR, CAE and BCC have been added to the Zacks Rank #5 (Strong Sell) List on December 29, 2025.
construction consumer-staples
2 Small Caps for the K-shaped Economy
by Mark Zinski
SENEA and NGVC are two food plays serving different consumers.
consumer-staples food
4 Cosmetics Stocks to Watch as the Market Resets for 2026
by Swati Prasad
EL, COTY, HELE and EWCZ face rising costs and changing demand, but innovation and digital expansion support their strategies.
consumer-staples
Do Options Traders Know Something About Ambev Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to ABEV stock based on the movements in the options market lately.
consumer-staples
CELH vs. MNST: Which Energy Drink Stock Is the Better Bet Now?
by Vrishali Bagree
Monster Beverage's global scale and margin strength face off against Celsius' rapid growth and innovation.
consumer-staples
ELF vs. EL: Which Beauty Stock Looks More Attractive Now?
by Vrishali Bagree
e.l.f. Beauty's value-driven growth faces off against Estee Lauder's recovery strategy as both adapt to shifting beauty demand.
consumer-staples
Best Income Stocks to Buy for Dec. 26
by Zacks Equity Research
JJSF, EXPD and EL made it to the Zacks Rank #1 (Strong Buy) income stocks list on Dec. 26, 2025.
consumer-staples
Best Value Stocks to Buy for Dec.26
by Zacks Equity Research
JJSF made it to the Zacks Rank #1 (Strong Buy) value stocks list on Dec. 26, 2025
consumer-staples
The Zacks Analyst Blog AbbVie, The Coca-Cola, Chevron, ImmuCell and Precipio
by Zacks Equity Research
AbbVie headlines today's top stock reports as Zacks highlights pharma recovery, resilient beverages and Chevron???s evolving energy outlook.
consumer-staples